Figure 1. Changes in HbA1c and anti-insulin antibody125I-binding rate following the change in dose of insulin glulisine and insulin glargine in anti-insulin antibody-positive insulin-treated diabetic patient.
| Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc |
| Journal website http://www.jofem.org |
Letter to the Editor
Volume 1, Number 5, December 2011, pages 234-236
The Treatment for Anti-insulin Antibody-mediated Immunological Insulin Resistance
Figure
Table
| Cessation of insulin administration [3] |
| Glucocorticoids [4] |
| Glucocorticoids / immunosuppressant / plasmapheresis [5] |
| Immunosuppressant / plasmapheresis [6] |
| Glucocorticoids / insulin linspro [7] |
| Insulin lispro [8] |
| Insulin glulisine [1] |
| Insulin glulisine / cessation of long-acting insulin analogs [2] |